Bruno Guerci

Summary

Affiliation: CHU de Nancy
Country: France

Publications

  1. ncbi request reprint Subcutaneous insulin: pharmacokinetic variability and glycemic variability
    B Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Hopital Jeanne d Arc, CHU de Nancy, France
    Diabetes Metab 31:4S7-4S24. 2005
  2. doi request reprint Gastric electrical stimulation for the treatment of diabetic gastroparesis
    B Guerci
    Service de Diabetologie, Maladies metaboliques et nutrition, Universite de Nancy I, CIC INSERM, CHU de Nancy, 54511 Vandoeuvre les Nancy, France
    Diabetes Metab 38:393-402. 2012
  3. ncbi request reprint Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study
    B Guerci
    Service de Diabetologie, Maladies Métaboliques and Maladies de la Nutrition, Hopital Jeanne d Arc, Centre Hospitalo Universitaire de Nancy, BP 303, Dommartin les Toul, 54201 Toul Cedex, France
    Diabetes Metab 29:587-94. 2003
  4. ncbi request reprint Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients
    Bruno Guerci
    Service de Diabetologie, Maladies Métaboliques and Maladies de la Nutrition, CIC INSERM, Hopital Jeanne d Arc, Nancy, France
    Diabetes Care 26:1137-41. 2003
  5. ncbi request reprint Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs
    Bruno Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Centre d Investigation Clinique INSERM CHU de NANCY Hôpital Jeanne d Arc, Centre Hospitalo Universitaire de Nancy, Toul cedex, France
    Diabetes Care 26:582-9. 2003
  6. ncbi request reprint [Continuous glucose monitoring: which benefits?]
    B Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Hôpital Jeanne d Arc CHU de Nancy, F 54201 Toul Cedex
    Ann Endocrinol (Paris) 65:S59-67. 2004
  7. ncbi request reprint [Glitazones clinical data: an update]
    B Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, CIC INSERM, CHU de Nancy, Hopital Jeanne d Arc, 54201 Toul Cedex, BP 303, France
    Ann Endocrinol (Paris) 66:1S45-58. 2005
  8. ncbi request reprint Analysis of the postprandial lipid metabolism: use of a 3-point test
    B Guerci
    Service de Diabetologie, Maladies Métaboliques and Maladies de la Nutrition, Centre d Investigation Clinique INSERM, CHU de Nancy, Hopital Jeanne d Arc, 54201 Toul Cedex, France
    Diabetes Metab 27:449-57. 2001
  9. ncbi request reprint Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus
    B Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Hopital Jeanne d Arc, CHU de Nancy, B P 303, 54201 Toul, Cedex
    Diabetes Metab 27:436-47. 2001
  10. ncbi request reprint Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function
    B Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Hopital Jeanne d Arc, CHU de Nancy, B P 303, 54201 Toul Cedex
    Diabetes Metab 27:425-34. 2001

Collaborators

Detail Information

Publications29

  1. ncbi request reprint Subcutaneous insulin: pharmacokinetic variability and glycemic variability
    B Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Hopital Jeanne d Arc, CHU de Nancy, France
    Diabetes Metab 31:4S7-4S24. 2005
    ..Their reduced variability should permit to reinforce near "physiological" insulin regimen such as "basal-bolus" technique and to consider new approaches and therapeutic strategies in type 1 and type 2 diabetic patients...
  2. doi request reprint Gastric electrical stimulation for the treatment of diabetic gastroparesis
    B Guerci
    Service de Diabetologie, Maladies metaboliques et nutrition, Universite de Nancy I, CIC INSERM, CHU de Nancy, 54511 Vandoeuvre les Nancy, France
    Diabetes Metab 38:393-402. 2012
    ..The enteral route should be preferred (nasojejunal and jejunostomy if possible efficiency). However, in case of failure especially in patients with small bowel neuropathy, the long-term parenteral nutrition is sometimes required...
  3. ncbi request reprint Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study
    B Guerci
    Service de Diabetologie, Maladies Métaboliques and Maladies de la Nutrition, Hopital Jeanne d Arc, Centre Hospitalo Universitaire de Nancy, BP 303, Dommartin les Toul, 54201 Toul Cedex, France
    Diabetes Metab 29:587-94. 2003
    ..An open label randomized prospective study was designed to compare changes in metabolic control over 6 months in patients managed with usual recommendations alone (conventional assessment group) or combined with SMBG...
  4. ncbi request reprint Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients
    Bruno Guerci
    Service de Diabetologie, Maladies Métaboliques and Maladies de la Nutrition, CIC INSERM, Hopital Jeanne d Arc, Nancy, France
    Diabetes Care 26:1137-41. 2003
    ..This study was designed to test the accuracy of capillary ketonemia for diagnosis of ketosis after interruption of insulin infusion...
  5. ncbi request reprint Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs
    Bruno Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Centre d Investigation Clinique INSERM CHU de NANCY Hôpital Jeanne d Arc, Centre Hospitalo Universitaire de Nancy, Toul cedex, France
    Diabetes Care 26:582-9. 2003
    ..Devices intended for use in the future, such as the continuous glucose monitoring system (CGMS), should satisfy similar criteria, particularly in diabetic patients under intensive therapy...
  6. ncbi request reprint [Continuous glucose monitoring: which benefits?]
    B Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Hôpital Jeanne d Arc CHU de Nancy, F 54201 Toul Cedex
    Ann Endocrinol (Paris) 65:S59-67. 2004
    ..The different techniques, the studies conducted in children and adult diabetic patients, as well as the main current indications for continuous glucose monitoring are described in this article...
  7. ncbi request reprint [Glitazones clinical data: an update]
    B Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, CIC INSERM, CHU de Nancy, Hopital Jeanne d Arc, 54201 Toul Cedex, BP 303, France
    Ann Endocrinol (Paris) 66:1S45-58. 2005
    ..This review describe and discuss the most recent studies and their results...
  8. ncbi request reprint Analysis of the postprandial lipid metabolism: use of a 3-point test
    B Guerci
    Service de Diabetologie, Maladies Métaboliques and Maladies de la Nutrition, Centre d Investigation Clinique INSERM, CHU de Nancy, Hopital Jeanne d Arc, 54201 Toul Cedex, France
    Diabetes Metab 27:449-57. 2001
    ..A simplified fat load test could be more convenient and more appropriate in routine clinical practice because of the number of lipid determinations required...
  9. ncbi request reprint Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus
    B Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Hopital Jeanne d Arc, CHU de Nancy, B P 303, 54201 Toul, Cedex
    Diabetes Metab 27:436-47. 2001
    ..Finally, recent reports indicate that an improved metabolic control in diabetic patients, whatever the treatment used, is associated with near normalization or restoration of normal endothelial function...
  10. ncbi request reprint Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function
    B Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Hopital Jeanne d Arc, CHU de Nancy, B P 303, 54201 Toul Cedex
    Diabetes Metab 27:425-34. 2001
    ..Finally, recent reports indicate that an improved metabolic control in diabetic patients, whatever the treatment used, is associated with near normalization or restoration of normal endothelial function...
  11. ncbi request reprint Advantages to using capillary blood beta-hydroxybutyrate determination for the detection and treatment of diabetic ketosis
    B Guerci
    Service de Diabetologie, Maladies metaboliques et nutrition, Hopital Jeanne d Arc, Route Nationale 4, 54201 Dommartin les Toul
    Diabetes Metab 31:401-6. 2005
    ..Indeed, it appears more appropriate, simple, descriptive and significant both for health-care staff and for patients...
  12. doi request reprint Exenatide: its position in the treatment of type 2 diabetes
    B Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, centre d investigation clinique, Hopital Jeanne d Arc, CHU de Nancy, B P 90303, 54201 Toul Cedex, France
    Ann Endocrinol (Paris) 69:201-9. 2008
    ..The aim of this article is to summarize main clinical data on exenatide and to discuss its position in current therapeutic strategy...
  13. ncbi request reprint Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients
    B Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, INSERM CHU de Nancy, Hopital Jeanne d Arc, Toul, France
    Diabetes Metab 25:412-8. 1999
    ..40, p < 0.05). Lipoprotein(a) appears to be associated with the severity of diabetic retinopathy in Type 1 diabetic patients, and particular attention should be paid to those with Lp(a) above 30 mg/dl and pre-proliferative retinopathy...
  14. ncbi request reprint [New hypoglycemic agents in type 2 diabetes]
    Bruno Guerci
    Université de Nancy I et service de diabétologie, Maladies Metaboliques et Maladies de la Nutrition, Hopital Jeanne d Arc, CHU de Nancy, 54201 Toul BP 90303
    Rev Prat 60:495-503. 2010
    ..However their effectiveness and long-term safety need to be evaluated...
  15. ncbi request reprint [Asymptomatic glycemic instability: how to measure it and which clinical applications? ]
    B Guerci
    Service de Diabetologie, Maladies Metaboliques et Maladies de la Nutrition, Centre d Investigation Clinique INSERM, CHU de Nancy, Hopital Jeanne d Arc, Centre Hospitalo Universitaire de Nancy, Toul, France
    Diabetes Metab 29:179-88. 2003
    ..The evaluation of glucose instability can be provided using new methods of glucose monitoring and could be useful to optimize the therapeutic regimens in some of these diabetic patients...
  16. ncbi request reprint Evolution of analytical performance in portable glucose meters in the last decade
    Philip Bohme
    Service de Diabetologie, Maladies Métaboliques and Maladies de la Nutrition, Hopital Jeanne d Arc, CHU Nancy, France
    Diabetes Care 26:1170-5. 2003
    ..To assess and compare the technical accuracy of portable glucose meters during the last decade...
  17. ncbi request reprint The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients
    Laurent Meyer
    Service de Diabetologie, Maladies Métaboliques and Maladies de la Nutrition, CIC INSERM, Hopital Jeanne d Arc, Centre Hospitalo Universitaire de Nancy, Toul, France
    Diabetes Care 25:2153-8. 2002
    ..This study was designed to assess the insulin-sparing effect of oral administration of metformin along with a continuous subcutaneous insulin infusion (CSII) for the treatment of type 1 diabetic patients...
  18. ncbi request reprint Increased ability of LDL from normolipidemic type 2 diabetic women to generate peroxides
    B Guerci
    Service de Diabetologie, Nutrition et Maladies Metaboliques, Centre Hospitalo Universitaire de Nancy Hôpital Jeanne d Arc, 54201 Toul cedex B P 303, France
    Clin Chem 45:1439-48. 1999
    ..The men and women in the diabetic groups were studied separately and matched for age, body mass index, duration of diabetes, glycohemoglobin, and conventional lipid characteristics according to the presence or absence of hyperlipidemia...
  19. ncbi request reprint [Physiopathology of obesity. Dietary factors, and regulation of the energy balance]
    O Ziegler
    Diabetologie, Maladies metaboliques et nutrition, Centre Hospitalier Universitaire de Nancy, Hopital Jeanne d Arc, 54201 Toul
    Ann Endocrinol (Paris) 61:12-23. 2000
    ..There is a need for more longitudinal studies on the role of macronutrient composition, food choice or eating disorders, especially among children, teenagers and young adults...
  20. ncbi request reprint Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients
    B Guerci
    Centre d Investigation Clinique INSERM Centre Hospitalier Universitaire de NANCY Hôpital Jeanne d Arc, Toul, France
    J Clin Endocrinol Metab 84:2673-8. 1999
    ..Thus, a short interruption of Lispro in CSII is associated with an earlier, greater metabolic deterioration, but Lispro corrected this metabolic deterioration more effectively...
  21. ncbi request reprint Evidence that diabetes mellitus favors impaired metabolism of zinc, copper, and selenium in chronic pancreatitis
    D Quilliot
    centre d investigation clinique, INSERM CHU, Centre Hospitalo Universitaire de Nancy, France
    Pancreas 22:299-306. 2001
    ..We have yet to determine whether the differences in trace-element status contribute to the clinical expression of the disease...
  22. ncbi request reprint [Macronutrients, fat mass, fatty acid flux and insulin sensitivity]
    O Ziegler
    Service de Diabétologiem Maladies Métaboliques et Nutrition, Centre Hospitalier Universitaire de Nancy, 54201 Toul Cedex, France
    Diabetes Metab 27:261-70. 2001
    ..Weight loss can induce marked improvement in insulin resistance, but weight maintenance is also required to keep long term good metabolic results...
  23. ncbi request reprint Effect of the inflammation, chronic hyperglycemia, or malabsorption on the apolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis
    D Quilliot
    Service de Diabetologie, Maladies metaboliques et nutrition, Hopital Jeanne d Arc, CHU de Nancy, Toul, France
    Metabolism 50:1019-24. 2001
    ..As apo A-IV is involved in reverse cholesterol transport, its low level in CP-DM may contribute to the accelerated development of atherosclerosis in these patients...
  24. doi request reprint New avenues for the pharmacological management of type 2 diabetes: an update
    Thomas Cuny
    University of Nancy I, Department of Endocrinology, University Hospital of Nancy Brabois, 54511 Vandoeuvre les Nancy, France
    Ann Endocrinol (Paris) 73:459-68. 2012
    ..Although there is genuine hope that the range of OADs can be extended, a long-term evaluation of side effects and true clinical benefits is necessary...
  25. ncbi request reprint [The "second atherogenic phenotype" or the role of insulin resistance in vascular risk]
    O Ziegler
    CHU de Nancy, , Toul
    Arch Mal Coeur Vaiss 91:33-9. 1998
    ..Therapeutic trials comparing the efficacy of statins and fibrates with respect to cardiovascular and global mortality should provide future information in this debate...
  26. ncbi request reprint Metformin and insulin in type 1 diabetes: the first step
    Laurent Meyer
    Diabetes Care 26:1655-6. 2003
  27. ncbi request reprint The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3
    Christine Bellanne-Chantelot
    Département de génétique, Groupe Hospitalier Pitie Salpetriere, Bât 6 rue Lapeyronie, 47 83 boulevard de l Hopital, 75651 Paris Cedex 13, France
    Diabetes 57:503-8. 2008
    ..This may be due to environmental and/or genetic factors, including molecular characteristics of the hepatocyte nuclear factor 1-alpha (HNF1A) gene mutation...
  28. ncbi request reprint New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome
    Aurélie Decaudain
    INSERM U680, Paris, F 75012 France
    J Clin Endocrinol Metab 92:4835-44. 2007
    ..We report here the phenotypes of the patients with non-codon 482 mutations and compare them with those of 11 patients with codon 482 mutations. We also studied skin fibroblasts or lymphocytes from seven patients...